Ads
related to: acute myeloid leukemia news- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- Unmet Needs In CML
Are Your Patients Experiencing
Intolerance? Learn About Treatment.
- View Patient Profiles
Search results
Moleculin's acute myeloid leukemia treatment gets EMA's orphan drug designation
Seeking Alpha· 1 day agoMoleculin Biotech's Annamycin receives Orphan Drug Designation from the European Medicines Agency for AML treatment, expanding its potential market reach.
DJ dead after cancer battle as fans mourn loss of 33-year radio veteran
The US Sun· 2 days agoFans of classic rock in Kansas City, Missouri have turned in their radios to listen to Slacker -...
Promising Treatment Approach for Aggressive Leukemia Identified
Technology Networks· 24 hours agoIn findings published in Nature Cancer, researchers revealed that blocking these oxygen-sensing...
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute ...
NBC 17 Raleigh· 1 day ago– Next-generation non-cardiotoxic anthracycline Annamycin with notable signs of clinical efficacy in AML in combination with Cytarabine achieves preliminary CRc rate of 60% in 2nd line AML subjects ...
Why Is Bio-Path (BPTH) Stock Up 89% Today?
InvestorPlace· 1 day agoBio-Path (NASDAQ:BPTH) stock is rising higher on Thursday after the oncology company announced an update on its Phase 1/1b clinical trial of BP1002. This...
Why Bio-Path Stock Is Soaring - Bio-Path Hldgs (NASDAQ:BPTH)
Benzinga· 1 day agoBPTH shares are trading higher Thursday after the company announced the completion of its second...
Utah dad gets second chance at life thanks to bone marrow transplant
KSL Salt Lake City· 19 hours agoMarc Dunbabin enjoys kicking the soccer ball around with his wife and three young kids. Dunbabin was...
Long-time Kansas City DJ loses battle with cancer
FOX 4 Kansas City· 2 days agoLong-time Kansas City DJ, Slacker, has passed away due to complications from leukemia.
Syros Pharmaceuticals (NASDAQ:SYRS) Stock Rating Lowered by StockNews.com
ETF DAILY NEWS· 20 hours agoSyros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on ...
Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101...
Investing.com· 5 days agoInnate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101...
Ads
related to: acute myeloid leukemia news
